- Home
- MIRM vs MSM Comparison
MIRM vs MSM Comparison
Compare MIRM & MSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIRM | MSM |
|---|---|---|
| Founded | 2018 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 6.7B |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MIRM | MSM |
|---|---|---|
| Price | $91.20 | $121.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 6 |
| Target Price | ★ $119.85 | $96.20 |
| AVG Volume (30 Days) | 464.4K | ★ 514.4K |
| Earning Date | 05-06-2026 | 04-01-2026 |
| Dividend Yield | N/A | ★ 3.45% |
| EPS Growth | ★ 74.59 | N/A |
| EPS | N/A | ★ 3.12 |
| Revenue | $19,138,000.00 | ★ $3,363,817,000.00 |
| Revenue This Year | $26.22 | $5.82 |
| Revenue Next Year | $22.04 | $5.26 |
| P/E Ratio | ★ N/A | $38.98 |
| Revenue Growth | N/A | ★ 4.99 |
| 52 Week Low | $63.23 | $78.80 |
| 52 Week High | $130.00 | $130.46 |
Technical Indicators
Market Signals| Indicator | MIRM | MSM |
|---|---|---|
| Relative Strength Index (RSI) | 37.91 | 51.81 |
| Support Level | $88.08 | $116.15 |
| Resistance Level | $98.03 | $122.92 |
| Average True Range (ATR) | 3.90 | 2.68 |
| MACD | -0.37 | 0.34 |
| Stochastic Oscillator | 10.13 | 72.56 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About MSM MSC Industrial Direct Company Inc.
Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations supplies. MSC primarily operates in North America, where it derives over 95% of its revenue.